NCT06730243

Brief Summary

To evaluate the impact of Retzius-sparing robot-assisted radical prostatectomy with "Sandwich" Technique of Total Urethral Reconstruction on early recovery of urinary continence (UC) compared to the conventional approach (anterior approach) and Laparoscopic Radical Prostatectomy for the treatment of clinically localized prostate cancer (PCa).Purpose: The trial compares outcomes between three groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

December 8, 2024

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 12, 2024

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

1.9 years

First QC Date

December 8, 2024

Last Update Submit

December 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • immediate urinary continence analysis

    Primary outcome was UC (defined as 0 pads/one security liner per day) after catheter removal

    1day,1month, 3 months after removal of the urinary cathete

Study Arms (3)

RS-RARP-S

EXPERIMENTAL

Retzius-sparing robot-assisted radical prostatectomy and "Sandwich" Technique of Total Urethral Reconstruction

Procedure: Retzius-sparing robot-assisted radical prostatectomy and "Sandwich" Technique of Total Urethral Reconstruction

S-RARP

EXPERIMENTAL

Standard RARP

Procedure: Standard Robot-Assisted Radical Prostatectomy

LRP

SHAM COMPARATOR

Laparoscopic Radical Prostatectomy

Procedure: Laparoscopic Radical Prostatectomy

Interventions

Retzius-sparing robot-assisted radical prostatectomy and "Sandwich" Technique of Total Urethral Reconstruction

RS-RARP-S

Standard Robot-Assisted Radical Prostatectomy

S-RARP

Laparoscopic Radical Prostatectomy

LRP

Eligibility Criteria

Age18 Years - 80 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histological verified prostate carcinoma (first diagnosis) Indication for primary curative radical prostatectomy Age ≤80 years Patient agrees to randomisation Patient is able to fill in the questionnaires on his own Patient is willing to provide written informed consent

You may not qualify if:

  • Insufficient knowledge of German Severe cognitive impairment Obesity (BMI \> 35) Current existing severe comorbidities (e.g. liver cirrhosis, second malignancy or relapse of every kind) Tumor stage: T4 Previous malignancy (≤ 3 years before trial participation) Neoadjuvant therapy (hormons) within the last 3 months before participation in the trial Patient is immuno-compromised History of intermittent urinary self-catheterization within the last year Psychological disorders (dementia, chronic depression, psychosis) Any of the following treatments ≤ 3 months before trial participation: surgery of the sigmoid colon, extended haemorrhoid resection, transurethral needle ablation of the prostate (TUNA), osteosynthesis of the pelvis, salvage prostatectomy Patients with chronic urinary infection Dialysis patients Lacking willingness for data storage and handling in the frame of the trial protocol/aims

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Center

Beijing, Beijing Municipality, 100021, China

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
National Cancer Center

Study Record Dates

First Submitted

December 8, 2024

First Posted

December 12, 2024

Study Start

January 1, 2023

Primary Completion

December 10, 2024

Study Completion

January 1, 2025

Last Updated

December 12, 2024

Record last verified: 2024-12

Locations